Next Generation News and Research

RSS

Study examines links between parental obesity and risk of autism developmental in child

Several studies have looked at possible links between maternal obesity during pregnancy and the risk of developmental disorders in the child. However, paternal obesity could be a greater risk factor than maternal obesity, according to a new study from the Norwegian Institute of Public Health.

8 Apr 2014

Continuous glucose monitoring in children: an interview with Terrance Gregg, CEO of Dexcom

Scientific research into CGM-like sensors goes back more than 40 years. I was working with the first company to begin commercial development, MiniMed, back in 1992 when the science was really beginning to percolate. In 1999 the FDA approved the first CGM device for use in the United States.

6 Apr 2014

Aesynt completes acquisition of Health Robotics

Aesynt™, a leading provider of integrated pharmacy automation solutions for hospitals and health systems, announced it has completed the acquisition of Health Robotics, the leading global supplier of automated technology for intravenous (IV) medication preparation, compounding and dispensing.

3 Apr 2014

Appistry unveils latest version of Broad Institute’s Genome Analysis Toolkit

Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine, today released the latest commercial version of the Broad Institute's Genome Analysis Toolkit (GATK).

3 Apr 2014

Auxogyn signs exclusive license agreement with Merck Serono for Eeva Test

Auxogyn, Inc., a company dedicated to advancing women's reproductive health, today announced an exclusive license agreement with Merck Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany which operates as EMD Serono in the United States and Canada, for Auxogyn's proprietary Early Embryo Viability Assessment (Eeva) Test.

3 Apr 2014

QIAGEN launches new products for next-generation sequencing applications

QIAGEN N.V. today announced two important new product launches which address workflow challenges in next-generation sequencing (NGS) applications.

From QIAGEN Manchester Limited 3 Apr 2014

Ethics experts issue decision-making guidelines to aid NASA for higher risk human spaceflights

Nearly two years after the conclusion of its space shuttle program left Americans wondering what would become of the spacefaring dreams of decades past, NASA has sought the advice of health and ethics experts for protecting astronauts on its "next generation" of long duration and exploration-class human spaceflights.

3 Apr 2014

BIO and WLSA to explore intersection between digital health and biotechnology at 2014 BIO International Convention

The Biotechnology Industry Organization (BIO) and the Wireless-Life Sciences Alliance (WLSA) today announced a partnership to explore the intersection between digital health and biotechnology through the inaugural Digital Health Zone and Forum at the 2014 BIO International Convention®.

3 Apr 2014

Fathers who started smoking before 11 tend to have obese sons

Men who started smoking regularly before the age of 11 had sons who, on average, had 5-10kg more body fat than their peers by the time they were in their teens, according to new research from the Children of the 90s study at the University of Bristol.

3 Apr 2014

ABL enters into licensing agreement with CRP-Santé for COMET software

Advanced Biological Laboratories (ABL) S.A., a Luxembourg-based company today announced that it has entered into an exclusive worldwide licensing agreement with CRP-Santé, a Luxembourg-based public research center active in the field of clinically oriented biomedical research, for its COMET (COntext-based Modeling for Expeditious Typing) software, a tool designed to rapidly analyze and optimally subtype large genetic data sets arising from epidemiological or antiretroviral resistance in the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) fields.

2 Apr 2014

Vestiage completes R&D for two new products

Vestiage™, Inc., the emerging leader in healthy aging, announced today that it has completed R&D for two new products that it intends to launch in upcoming quarters.

2 Apr 2014

EMD Serono collaborates with Pfizer and Broad Institute

EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, today announced they have signed a research agreement with Pfizer Inc. and the Broad Institute in Cambridge, Massachusetts, U.S. The collaboration is focused on the genomic profiling of Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (LN) patients.

1 Apr 2014

GIN and Sigolis merge to create new company, Ginolis Oy

Global Innovation Network Oy (GIN) and Sigolis AB today announced a merger of the two companies. The new company, named Ginolis Oy, provides an innovative one-stop solution for the development and manufacturing of in vitro diagnostic (IVD) disposable products.

1 Apr 2014

22 new Centres for Doctoral Training

Postgraduate training in a wide range of engineering and scientific fields important to the UK's economy received a further boost today. Twenty two new Centres for Doctoral Training (CDTs) were announced by the Chancellor of the Exchequer, The Rt. Hon George Osborne MP.

1 Apr 2014

Massachusetts Life Sciences Center provides $1.65M in capital grant to North Shore InnoVentures

North Shore InnoVentures, one of New England's leading technology incubators and business accelerators, announced today that it has received a capital grant of $1.65 million from the Massachusetts Life Sciences Center.

From Evident Corporation - Life Sciences 28 Mar 2014

NARSAD grants to fund research into psychiatric illness by 40 mid-career scientists

The Brain & Behavior Research Foundation today announced its 2014 NARSAD Independent Investigator Grants, which will award $4 million in funding to 40 mid-career scientists from 33 institutions in nine countries. Selected by the Foundation's Scientific Council, comprised of 146 leading experts across disciplines in brain and behavior research including two Nobel Prize winners, the grants fund basic research, new technologies and next generation therapies for schizophrenia, major affective disorders, and other serious mental illnesses.

28 Mar 2014

Personalis and Inova team up to advance genomic medicine

Inova Translational Medicine Institute and Personalis, Inc. today announced a partnership to advance genomic medicine for Inova's patient population.

27 Mar 2014

New strain of rice may help combat obesity and other diseases

In recent years, Okinawa has recorded the dubious distinction of having the highest obesity rate in Japan. Preventing obesity-related diseases is an urgent issue.

27 Mar 2014

Researchers to discuss implications of genomic sequencing at ACMG meeting

Researchers from the Mayo Clinic Center for Individualized Medicine will present results of three different studies evaluating implications and feasibility of genome sequencing at the ACMG Annual Clinical Genetics Meeting this week in Nashville, Tenn.

27 Mar 2014

Shimadzu announces FDA approval for new digital angiography systems

Shimadzu Medical Systems USA has announced that a new digital angiography system family has received 510(k) clearance from the U.S. Food and Drug Administration. These are the ceiling-mounted Trinias, the floor-mounted Trinias, and the Biplane models.

27 Mar 2014